NUTF2 and neoplasm: Moreover, we discussed the prognostic value of NUTF2 in HNSCC by DFS analysis, which excludes patients who survive but relapse with HNSCC, offering patients a direct clinical benefit on tumor recurrence and can be a more valuable survival index.